CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effect...
Saved in:
Main Authors: | Shazia Jamal, Vino T Cheriyan, Magesh Muthu, Sara Munie, Edi Levi, Abdelkader E Ashour, Harvey I Pass, Anil Wali, Mandip Singh, Arun K Rishi |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomegalovirus infection in malignant pleural mesothelioma.
by: DeVon Hunter-Schlichting, et al.
Published: (2021) -
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016) -
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
by: Anca Nastase, et al.
Published: (2021) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
by: Sara Ricciardi, et al.
Published: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
by: Bonomi M, et al.
Published: (2017)